{"version":"1.0","type":"link","title":"Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.","author_name":"Redfern A 외","author_url":"https://prs-insight.online/author/Redfern%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/74734","thumbnail_width":1200,"thumbnail_height":630}